S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
NASDAQ:SYNH

Syneos Health (SYNH) Stock Forecast, Price & News

$70.91
+1.14 (+1.63%)
(As of 05/20/2022 04:00 PM ET)
Add
Compare
Today's Range
$68.98
$71.34
50-Day Range
$67.33
$84.75
52-Week Range
$66.73
$104.18
Volume
425,759 shs
Average Volume
787,458 shs
Market Capitalization
$7.27 billion
P/E Ratio
30.70
Dividend Yield
N/A
Beta
1.79
30 days | 90 days | 365 days | Advanced Chart
Receive SYNH News and Ratings via Email

Sign-up to receive the latest news and ratings for Syneos Health and its competitors with MarketBeat's FREE daily newsletter.

Syneos Health logo

About Syneos Health

Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Commercial physical research
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SYNH
Employees
28,000
Year Founded
N/A

Sales & Book Value

Annual Sales
$5.21 billion
Cash Flow
$6.39 per share
Book Value
$32.19 per share

Profitability

Net Income
$234.83 million
Pretax Margin
6.02%

Debt

Price-To-Earnings

Miscellaneous

Free Float
102,226,000
Market Cap
$7.27 billion
Optionable
Optionable

Company Calendar

Last Earnings
4/29/2022
Today
5/21/2022
Next Earnings (Estimated)
8/08/2022
Fiscal Year End
12/31/2022

MarketRank

Overall MarketRank

2.22 out of 5 stars

Medical Sector

356th out of 1,420 stocks

Commercial Physical Research Industry

5th out of 23 stocks

Analyst Opinion: 3.4Community Rank: 4.8Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -













Syneos Health (NASDAQ:SYNH) Frequently Asked Questions

Is Syneos Health a buy right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Syneos Health in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Syneos Health stock.
View analyst ratings for Syneos Health
or view top-rated stocks.

When is Syneos Health's next earnings date?

Syneos Health is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for Syneos Health
.

How were Syneos Health's earnings last quarter?

Syneos Health, Inc. (NASDAQ:SYNH) announced its quarterly earnings data on Friday, April, 29th. The company reported $1.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.95 by $0.06. The firm had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.32 billion. Syneos Health had a net margin of 4.54% and a trailing twelve-month return on equity of 13.33%. Syneos Health's revenue for the quarter was up 10.5% on a year-over-year basis. During the same period in the previous year, the firm earned $0.66 earnings per share.
View Syneos Health's earnings history
.

What guidance has Syneos Health issued on next quarter's earnings?

Syneos Health updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share guidance of $5.05-$5.25 for the period, compared to the consensus EPS estimate of $5.08. The company issued revenue guidance of $5.60 billion-$5.75 billion, compared to the consensus revenue estimate of $5.65 billion.

What price target have analysts set for SYNH?

8 Wall Street analysts have issued twelve-month price objectives for Syneos Health's shares. Their forecasts range from $75.00 to $122.00. On average, they expect Syneos Health's stock price to reach $101.00 in the next year. This suggests a possible upside of 42.4% from the stock's current price.
View analysts' price targets for Syneos Health
or view top-rated stocks among Wall Street analysts.

Who are Syneos Health's key executives?
Syneos Health's management team includes the following people:
What is Alistair Macdonald's approval rating as Syneos Health's CEO?

322 employees have rated Syneos Health CEO Alistair Macdonald on Glassdoor.com. Alistair Macdonald has an approval rating of 82% among Syneos Health's employees.

What other stocks do shareholders of Syneos Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Syneos Health investors own include NVIDIA (NVDA), Pfizer (PFE), Square (SQ), Advanced Micro Devices (AMD), Boeing (BA), Alibaba Group (BABA), ICON Public (ICLR), Netflix (NFLX), AbbVie (ABBV) and Intel (INTC).

What is Syneos Health's stock symbol?

Syneos Health trades on the NASDAQ under the ticker symbol "SYNH."

Who are Syneos Health's major shareholders?

Syneos Health's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (11.24%), Vanguard Group Inc. (9.48%), Wellington Management Group LLP (9.19%), Clearbridge Investments LLC (3.80%), Massachusetts Financial Services Co. MA (2.80%) and State Street Corp (2.59%). Company insiders that own Syneos Health stock include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, John L Maldonado, John M Dineen, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Michael Lee Brooks, Michelle Keefe, Thomas H Lee Advisors, Llc and Tom Allen.
View institutional ownership trends for Syneos Health
.

Which institutional investors are selling Syneos Health stock?

SYNH stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, Healthcare of Ontario Pension Plan Trust Fund, Strs Ohio, Wellington Management Group LLP, Dana Investment Advisors Inc., GW&K Investment Management LLC, Russell Investments Group Ltd., and Envestnet Asset Management Inc.. Company insiders that have sold Syneos Health company stock in the last year include Alistair Macdonald, Donna Hildebrand Kralowetz, International Corp/Ma Advent, Jason M Meggs, Jonathan Olefson, Linda S Harty, Mark E Jagiela, Matthew E Monaghan, Michael Lee Brooks, and Thomas H Lee Advisors, Llc.
View insider buying and selling activity for Syneos Health
or view top insider-selling stocks.

Which institutional investors are buying Syneos Health stock?

SYNH stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Massachusetts Financial Services Co. MA, Cooke & Bieler LP, Goldman Sachs Group Inc., Crestwood Advisors Group LLC, Clearbridge Investments LLC, Assenagon Asset Management S.A., and The Manufacturers Life Insurance Company .
View insider buying and selling activity for Syneos Health
or or view top insider-buying stocks.

How do I buy shares of Syneos Health?

Shares of SYNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Syneos Health's stock price today?

One share of SYNH stock can currently be purchased for approximately $70.91.

How much money does Syneos Health make?

Syneos Health has a market capitalization of $7.27 billion and generates $5.21 billion in revenue each year. The company earns $234.83 million in net income (profit) each year or $2.31 on an earnings per share basis.

How many employees does Syneos Health have?

Syneos Health employs 28,000 workers across the globe.

What is Syneos Health's official website?

The official website for Syneos Health is www.syneoshealth.com.

How can I contact Syneos Health?

Syneos Health's mailing address is 1030 Sync Street, Morrisville NC, 27560. The company can be reached via phone at (919) 876-9300, via email at [email protected], or via fax at 919-876-9360.

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.